The allotment process for the IPO of Sopan Pharmaceuticals Limited has been successfully concluded today at the premises of the issue manager, NMB Capital Limited, Baluwatar, Kathmandu. The final results were announced following a computerized lottery system used due to high investor interest.
IPO Issue Overview
Sopan Pharmaceuticals Limited had issued a total of 3,474,900 units of ordinary shares to the general public as part of its initial public offering. The IPO was open for subscription from 3rd Baishakh, 2083 to 8th Baishakh, 2083, allowing retail investors to participate.
- Total Issued Capital: NPR 1.71 Arba
- Shares Offered: 34,74,900 units for the general public
- Applications Received: 27,30,987 valid applications requesting 2,99,06,520 units
- Disqualified Applications: 37,756 applications for 4,60,430 units
Because the number of applications far exceeded the available shares, the allotment was done through a lottery system, as per the Securities Issuance and Allotment Guidelines.
Allotment Results — Who Got Shares?
According to the official results:
👉 3,47,490 applicants were allotted 10 shares each through the lottery system.
If you applied for the IPO, you can now check your individual allotment result online.
🔗 Check Your Allotment Result: https://iporesult.freerojgari.com/
Other ways to view your result include:
- CDSC IPO Result Portal
- MeroShare Account
Just enter your BOID (Beneficial Owner Identification) number and click “View Result” on the portal.
Company Background
Sopan Pharmaceuticals Limited (SPL) is a publicly held pharmaceutical company incorporated in 2009. The company manufactures a wide range of generic and cephalosporin drugs at its facility in Lalitpur, Nepal. It holds licenses for 139 categories of drugs for production and 70 products for marketing within Nepal.
The issuer’s credit rating was recently upgraded by CARE Ratings Nepal Limited (CRNL) — from CARE-NP B- (Is) to CARE-NP B (Is) — signaling a high level of risk, which investors should consider.
Implications for Investors
Since the IPO was heavily oversubscribed, only a small fraction of applicants received the minimum allotment (10 shares). Investors who were not allotted shares will typically have the IPO application funds refunded automatically in their respective bank accounts as per standard processing timelines.
Early participation in IPOs with strong subscriptions reflects increased market participation and investor interest in Nepal’s primary market. However, investors should always consider long-term fundamentals and consult financial advisors before applying to future offerings.
How to Check Your IPO Result
To check the result quickly:
- Visit the IPO result portal: https://iporesult.freerojgari.com/
- Select Sopan Pharmaceuticals Limited IPO
- Enter your 16-digit BOID number
- Click View Result
Alternatively, you can log in to your MeroShare account (CDSC) or check via the CDSC IPO Result official page.